The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on October 22, 2026

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment
Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026
Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
MACOM to Report Fourth Quarter and Fiscal Year 2026 Financial Results on November 5, 2026
Candel Therapeutics Appoints Maria Ostrovsky as General Counsel
First Steps Developmental Services Opens Infant Assessment in Woburn
Jules Kortenhorst Joins GeoRedox as Non-Executive Chair
Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026
Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026
Cambridge Heavy Industries Raises $6.2 Million Seed Round to Advance its Modular, Benchtop-scale Fusion System Technology
Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases
Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026
Aspen Aerogels, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call
Rgenta Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Trial Design for RGT-61159 in Patients with Adenoid Cystic Carcinoma (ACC)
Does mobile technology integration improve the speed and equity of resolving government service requests?
Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
BPGbio Appoints Jason Krause as Senior Vice President and General Counsel
Apollo Therapeutics Announces Science Translational Medicine Publication Supporting APL-9796 as a Potential Disease-Modifying Approach for Pulmonary Hypertension
Generate Biomedicines to Participate in November Investor Conferences
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.